deferoxamine has been researched along with Atopic Hypersensitivity in 1 studies
Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.
Excerpt | Relevance | Reference |
---|---|---|
"Thalassemia major is an inherited form of chronic hemolytic anemia that results in iron overload due to regular blood transfusions." | 5.40 | Modified desensitization protocols for a pediatric patient with anaphylactic reaction to deferoxamine. ( Poachanukoon, O; Satayasai, W; Silapamongkonkul, P; Surapolchai, P, 2014) |
"Thalassemia major is an inherited form of chronic hemolytic anemia that results in iron overload due to regular blood transfusions." | 1.40 | Modified desensitization protocols for a pediatric patient with anaphylactic reaction to deferoxamine. ( Poachanukoon, O; Satayasai, W; Silapamongkonkul, P; Surapolchai, P, 2014) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Surapolchai, P | 1 |
Poachanukoon, O | 1 |
Satayasai, W | 1 |
Silapamongkonkul, P | 1 |
1 other study available for deferoxamine and Atopic Hypersensitivity
Article | Year |
---|---|
Modified desensitization protocols for a pediatric patient with anaphylactic reaction to deferoxamine.
Topics: Adolescent; Anaphylaxis; beta-Thalassemia; Blood Transfusion; Deferoxamine; Desensitization, Immunol | 2014 |